[{"NetIncomeLoss_1_Q2_USD":-68743782.0,"GeneralAndAdministrativeExpense_1_Q2_USD":69851164.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":81088900.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":81229788.0,"RestrictedCashCurrent_0_Q2_USD":1400000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":3332960.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.949,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":20.64,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":176118.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":165063050.0,"Depreciation_2_Q2_USD":252589.0,"Depreciation_1_Q2_USD":125581.0,"PaymentsToAcquireInvestments_2_Q2_USD":119898620.0,"GeneralAndAdministrativeExpense_2_Q2_USD":122434803.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":16.38,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":3013355.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":1581697.0,"AssetsCurrent_0_Q2_USD":601303244.0,"OperatingLeaseExpense_2_Q2_USD":1600000.0,"OperatingLeaseExpense_1_Q2_USD":800000.0,"CommonStockSharesIssued_0_Q2_shares":81311878.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":1410294.0,"StockIssuedDuringPeriodValueIssuedForServices_2_Q2_USD":105465.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q2_USD":51923.0,"Assets_0_Q2_USD":625696662.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-304466.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-70427.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_Q2_shares":674309.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":18.58,"MoneyMarketFundsAtCarryingValue_0_Q2_USD":97100000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":433551000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":20.64,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-304466.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-70427.0,"AccountsReceivableNetCurrent_0_Q2_USD":15187814.0,"IncomeTaxExpenseBenefit_2_Q2_USD":28756.0,"IncomeTaxExpenseBenefit_1_Q2_USD":23756.0,"CommonStockValue_0_Q2_USD":8132.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":23086.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":102000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":3013355.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":433727230.0,"IncreaseDecreaseInInventories_2_Q2_USD":712463.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":14054009.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-121788191.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-68814209.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":14832115.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":10438931.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0086,"OtherAssetsNoncurrent_0_Q2_USD":86084.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":121030152.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":21688851.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":284976914.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1611989381.0,"Liabilities_0_Q2_USD":72110788.0,"OperatingLeaseLiability_0_Q2_USD":27300000.0,"ShareBasedCompensation_2_Q2_USD":15395141.0,"ShareBasedCompensation_1_Q2_USD":8616704.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":22546333.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":4224616.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1058587757.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":60984219.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":4423231.0,"CommonStockSharesOutstanding_0_Q2_shares":81311878.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":5978636.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q2_USD":203600000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":4289138.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-121454969.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-68720026.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":15395141.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8616705.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-107092186.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":3025594.0,"LiabilitiesCurrent_0_Q2_USD":50421937.0,"AccountsPayableCurrent_0_Q2_USD":15940756.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":122430152.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":22189200.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.945,"ProceedsFromStockOptionsExercised_2_Q2_USD":3013355.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":102000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_2_Q2_USD":105465.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":150481.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1761001.0,"NetIncomeLoss_2_Q2_USD":-121483725.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5978636.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17296420.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":1707864.0,"StockholdersEquity_0_Q2_USD":553585874.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":7953745.0,"CommonStockSharesAuthorized_0_Q2_shares":175000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":35924890.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":20046561.0,"ImpairmentOfLongLivedAssetsHeldForUse_2_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":-122359747.0,"OperatingIncomeLoss_1_Q2_USD":-69141054.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":120000.0,"InventoryNet_0_Q2_USD":7768848.0,"InvestmentIncomeInterest_2_Q2_USD":904778.0,"InvestmentIncomeInterest_1_Q2_USD":421028.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":278000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":30.45,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":19.29,"OperatingLeaseCost_2_Q2_USD":1200000.0,"OperatingLeaseCost_1_Q2_USD":585256.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":625696662.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":6050139.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5595057.0,"OperatingExpenses_2_Q2_USD":158284637.0,"OperatingExpenses_1_Q2_USD":89187615.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":3076528.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":270846.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.5,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.85,"ProfitLoss_2_Q2_USD":-121483725.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":15244.0,"ResearchAndDevelopmentExpense_2_Q2_USD":32354588.0,"Ticker":"ITCI","CIK":"1567514","name":"INTRA-CELLULAR THERAPIES, INC.","OfficialName":"Intra-Cellular Therapies Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"5718578003.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]